Brendan Heiden View Appointment Options Brendan Heiden Appointment Options Research & Selected Publications Share Copy Link Email Link Print Page Facebook X Instagram LinkedIn Back Gmail Outlook Apple Mail Yahoo! Mail Appointment Options Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you. Request an Appointment Call Us Refer a Patient Research & Selected Publications Characterizing phantom lymph node collection during curative-intent resection of non-small cell lung cancer Characterizing phantom lymph node collection during curative-intent resection of non-small cell lung cancer Authors: Ghani A, Seyoum N, Eaton DB, [...]one or more additional authors omitted Heiden BT Journal & Year: J Thorac Cardiovasc Surg | 2026 Adherence to Postoperative Survivorship Quality Metrics in Early-Stage Non-Small Cell Lung Cancer Adherence to Postoperative Survivorship Quality Metrics in Early-Stage Non-Small Cell Lung Cancer Authors: Seyoum N, Eaton DB, Tohmasi S, [...]one or more additional authors omitted Heiden BT Journal & Year: Ann Thorac Surg | 2026 Availability of multidisciplinary treatment modalities and outcomes among patients with resected early-stage non-small cell lung cancer Availability of multidisciplinary treatment modalities and outcomes among patients with resected early-stage non-small cell lung cancer Authors: Heiden BT, Eaton DB, Palta J, [...]one or more additional authors omitted Moghanaki D Journal & Year: JNCI Cancer Spectr | 2025 Smoking Cessation and Mortality Risk in Cancer Survivorship: Real-World Data From a National Cancer Institute-Designated Cancer Center Smoking Cessation and Mortality Risk in Cancer Survivorship: Real-World Data From a National Cancer Institute-Designated Cancer Center Authors: Tohmasi S, Baker TB, Heiden BT, [...]one or more additional authors omitted Chen LS Journal & Year: J Natl Compr Canc Netw | 2025 Real-World Adoption of Adjuvant Therapies for Resected Stage IB-III Non-Small-Cell Lung Cancer Real-World Adoption of Adjuvant Therapies for Resected Stage IB-III Non-Small-Cell Lung Cancer Authors: Kumar A, Tohmasi S, Eaton DB, [...]one or more additional authors omitted Heiden BT Journal & Year: Cancers (Basel) | 2025
